Stay updated on DLL3-Expressing Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the DLL3-Expressing Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DLL3-Expressing Advanced Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-30T13:55:04.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-23T08:24:14.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the removal of detailed study descriptions and inclusion/exclusion criteria for a clinical trial related to advanced cancers, while adding new identifiers and collaborators for a study on Small-Cell Lung Cancer.
    Difference
    12%
    Check dated 2025-04-16T01:49:54.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4 and has added several new dates for future events, while removing some past dates.
    Difference
    0.3%
    Check dated 2025-04-08T20:36:41.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 20, 2025, and version 2.14.2.
    Difference
    0.1%
    Check dated 2025-04-01T18:03:55.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new study involving gocatamig, replacing the previous study on MK-6070. Key details include dosing schedules and pharmacokinetic parameters for gocatamig, which are critical for understanding the treatment's administration and effects.
    Difference
    3%
    Check dated 2025-03-03T22:14:49.000Z thumbnail image

Stay in the know with updates to DLL3-Expressing Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DLL3-Expressing Advanced Cancer Clinical Trial page.